Jellagen Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.37M
Latest Deal Amount
  • Investors
  • 10

Jellagen General Information

Description

Manufacturer of collagen products designed to application in 2D and 3D cell culture and medical devices. The company's products offer non-mammalian jellyfish collagen ranging from in-vitro to in-vivo applications as well as a batch to batch consistency offering advantages to research and medical applications, enabling medicinal researchers to conduct in-house research and development and to support fabrication of new medical devices offering new approaches to wound management and tissue engineering.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Unit G6, Capital Business Park
  • Parkway St Mellons
  • Cardiff CF3 2PY
  • Wales, United Kingdom
+44 0333 000 0000

Jellagen Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jellagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 25-Jun-2020 $2.37M 000.00 000.00 Completed Generating Revenue
6. Early Stage VC 09-Apr-2019 00000 00.00 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 20-Feb-2019 00000 00.000 Completed Generating Revenue
4. Early Stage VC 27-Apr-2018 00.000 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 15-Dec-2016 00.00 00.00 00.000 Completed Startup
2. Early Stage VC 02-Sep-2015 $895K $895K 00.000 Completed Startup
1. Grant 17-Aug-2015 $3.07M Completed Startup
To view Jellagen’s complete valuation and funding history, request access »

Jellagen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preferred Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary A 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preferred Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Preferred Ordinary 4,227 $0.012506 $118.36 $118.36 1x $118.36 7.98%
A Ordinary 1,849 $0.012506 $118.36 $118.36 1x $118.36 3.49%
To view Jellagen’s complete cap table history, request access »

Jellagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of collagen products designed to application in 2D and 3D cell culture and medical devices. The company's p
Biotechnology
Cardiff, United Kingdom
15 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

000000 0

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo co
0000000000000
Quebec, Canada
00 As of 0000
000.00
0000000000 000.00

00000000

unt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
0000000000000
Chaponost, France
00 As of 0000
00 000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jellagen Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Feldan Therapeutics Venture Capital-Backed Quebec, Canada 00 000.00 0000000000 000.00
00000000 Private Equity-Backed Chaponost, France 00 00 000000
0000000000 000000 Venture Capital-Backed Alderley Edge, United Kingdom 00 00.000 000000 - 000 00.000
00000000 000000000 Formerly VC-backed San Diego, CA 0 000000&0
00000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 00000000000 00.000
You’re viewing 5 of 7 competitors. Get the full list »

Jellagen Patents

Jellagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201708853-D0 Method Ceased 02-Jun-2017 000000000
EP-3630810-A1 Method for the purification of collagen Pending 02-Jun-2017 000000000
US-20210139533-A1 Method for the purification of collagen Pending 02-Jun-2017 000000000
EP-3509649-A1 Method for producing collagen hydrogels Granted 07-Sep-2016 0000000000
EP-3509649-B1 Method for producing collagen hydrogels Active 07-Sep-2016 A61L15/60

Jellagen Executive Team (6)

Name Title Board Seat Contact Info
Thomas-Paul Descamps Chief Executive Officer & Board Member
Stephen Fairey Chief Financial Officer, Member of the Executive Committee and Board Observer
Andrew Mearns-Spragg Ph.D Co-Founder, Chief Scientific Officer, Board Member & Chairman of Scientific Advisory Board
Almero Barnard Chief Manufacturing Officer & Head of Site
Andy Weymann MD Chief Medical Officer & Scientific Advisory Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Jellagen Board Members (9)

Name Representing Role Since
Andrew Mearns-Spragg Ph.D Jellagen Co-Founder, Chief Scientific Officer, Board Member & Chairman of Scientific Advisory Board 000 0000
Andrew Shearer Jellagen Board Observer & Business Development Advisor 000 0000
Andy Weymann MD Self Chief Medical Officer & Scientific Advisory Board Member 000 0000
Berent Wallendahl Self Board Member 000 0000
Gregg Sando Self Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Jellagen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jellagen Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angels Invest Wales Angel Group Minority 000 0000 000000 0
MedCity Corporation Minority 000 0000 000000 0
Newable Corporation Minority 000 0000 000000 0
Angels in Med City Angel Group Minority 000 0000 000000 0
London Business Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »